Ormco announces sole U.S. distribution of improved OrthoPulse Gen.2 device

Reducing treatment time for patients by up to 50 percent, this gentle and noninvasive system has received structural and technological improvements, such as:

• Increased battery capacity.
• Water-protecting design in charging case and mouthpiece.
• Plastic chassis for flex circuit in mouthpiece to help reduce risk of broken wires.
• “Backbone” reinforced on mouthpiece structure.
• New version of app with advanced quality of life updates.

“Through modification of a patient’s biological response to treatment, and hence shortening the orthodontic timeline, patients and doctors find this device invaluable, which is why we are so excited to announce that Ormco is the sole U.S. distributor for the latest version of the already popular OrthoPulse device,” said Jim McGillivary, president of Ormco. “Giving fixed and aligner patients more comfort and significantly lessening treatment time — while shortening chair time and increasing predictive outcomes — are all important aspects of our core business.”

“Thanks to the innovative technology of OrthoPulse, my patients can safely and effectively accelerate their orthodontic treatment,” said Dr. Jeff Summers. “OrthoPulse integrates easily into their daily routine, and we are also seeing that it is gentle and comfortable to help reduce pain and discomfort associated with treatment.”

OrthoPulse is a clinically proven and FDA-approved medical device using low levels of light energy to stimulate the bone surrounding the roots of teeth and facilitate tooth movement, accelerating orthodontic treatment with fixed braces and clear aligners by up to 50 percent. The device is designed to be used at home by the patient for 10 minutes daily.

To learn more about the OrthoPulse Gen.2, visit ormco.com/orthopulse.

Tags: